Mia Hamm fronts GSK vaccine awareness effort

Share this article:
Mia Hamm fronts GSK vaccine awareness effort
Mia Hamm fronts GSK vaccine awareness effort

GlaxoSmithKline tapped soccer phenom Mia Hamm for a new vaccine awareness campaign promoting vaccines as an integral part of adult health. Hamm fronted a MedImmune/AstraZeneca flu vaccine awareness campaign last summer.

The GSK campaign, titled Give Your Health A Shot, promotes adult vaccination in general – from flu and whooping cough to hepatitis A and B, HPV and meningococcal vaccines – as a necessary part of “a healthy plan for living,” according to GSK spokesperson Amy Searfoorce.

The campaign website offers information about vaccines, including the Centers for Disease Control and Prevention (CDC) recommendation that “adults be vaccinated against up to 14 diseases.” Eight vaccines are detailed on the website, but no brand names are discussed.

The American College of Physicians (ACP), and Brad Moore, an ACP fellow, are also partners on the campaign, with Moore and Hamm appearing in a DVD available as part of a guidebook for download on the website. The 30-page guidebook (including information about vaccines, healthy living, and a checklist for patients to use in the doctor's office) and DVD was created by GSK and the ACP, with producers Conrad & Associates and Alan Weiss Productions. Hamm and Moore were both compensated for their participation – as noted on the site – but dollar amounts were not immediately available, per Searfoorce.

Hamm conducted various interviews with media outlets today, said Searfoorce, but no further events or print advertising (beyond the guidebook) is scheduled. In October, video from the DVD will run as a 30-minute televised PSA in a handful of markets, including St. Louis, San Francisco, Detroit, Atlanta and Washington DC, said Searfoorce.

GSK currently markets five vaccines for adults in the US, coinciding with the recommendations on the site, as follows:

  • Influenza: Fluarix, FluLaval
  • Human papillomavirus (HPV): Cervarix
  • Hepatitis A: Havrix
  • Hepatitis B: Engerix-B
  • Hepatitis A&B: Twinrix
  • Whooping cough (Tdap): Boostrix
Share this article:

Email Newsletters

More in News

Sanofi tightens PCSK9 race, exceeds Q2 expectations

Sanofi tightens PCSK9 race, exceeds Q2 expectations

Sanofi and partner Regeneron attached a $67.5-million priority review voucher to their experimental cholesterol drug alirocumab, miaking for a tighter race with Amgen.

AstraZenca beefs up respiratory portfolio

AstraZenca beefs up respiratory portfolio

AstraZeneca has made an $875-million move to beef up its respiratory pipeline by making Almirall's lineup its own.

Amgen Q2 sales rise, company to lay off up to 2,900

Amgen Q2 sales rise, company to lay off ...

The majority of the layoffs will be in the US.